TRILEPTAL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TRILEPTAL contains one active pharmaceutical ingredient (API):

1 Oxcarbazepine
UNII VZI5B1W380 - OXCARBAZEPINE

The pharmacological activity of oxcarbazepine is primarily exerted through the metabolite (MHD). The mechanism of action of oxcarbazepine and MHD is thought to be mainly based on the blockade of voltage-sensitive sodium channels.

Read about Oxcarbazepine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TRILEPTAL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AF02 Oxcarbazepine N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8584T, 8585W, 8586X, 8588B
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526515403119316, 526515404115314, 526515405111312, 526515408110317, 526515409117315, 526515410131415
Country: CA Health Products and Food Branch Identifier(s): 02242068, 02242069, 02244673
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.199-08-06, 27.284-10-06, 367430813
Country: EE Ravimiamet Identifier(s): 1009662, 1009673, 1009684, 1077230, 1077263, 1077274
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 63093, 63095, 64398
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 422178, 552901, 556936, 556951
Country: FR Base de données publique des médicaments Identifier(s): 61556061, 64876757, 66064587, 69568788
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 140118, 146852, 146854, 146856, 162799, 162801, 186172, 36728, 369022, 369024, 374086, 37842, 381715, 38401, 394092, 73155
Country: HK Department of Health Drug Office Identifier(s): 49918, 50007, 50215
Country: IE Health Products Regulatory Authority Identifier(s): 29236, 37405, 44625, 49812, 49833, 49886, 74950, 74951
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1002221, 1002223, 1014734
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 236M90, 362M94
Country: NL Z-Index G-Standaard Identifier(s): 14896214
Country: NL Z-Index G-Standaard, PRK Identifier(s): 56863, 56871, 70483
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8716, 8718, 8719, 9885
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100096439, 100096445, 100189744, 100232196, 100350122, 100355680, 100357822, 100375926, 100376009
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W51416001, W51416002, W51416003, W51416004, W51416005, W51417001, W51417002, W51417003, W51417004, W51417005
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504090550, 8699504090604, 8699504700008
Country: US FDA, National Drug Code Identifier(s): 0078-0337, 0078-0357, 0078-0456, 0078-0457, 55289-007
Country: ZA Health Products Regulatory Authority Identifier(s): 34/2.5/0442, 36/2.5/0409, X/2.5/205, X/2.5/206

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.